
Peptides
Peptides are short chains of amino acids linked by peptide bonds, serving as important biological molecules that play key roles in cellular processes. They function as hormones, neurotransmitters, and signaling molecules, and are widely used in therapeutic and diagnostic applications. Peptides are also crucial in research for studying protein interactions, enzyme activities, and cell signaling pathways. At CymitQuimica, we provide a diverse selection of high-quality peptides to support your research and development needs in biotechnology and pharmaceuticals.
Subcategories of "Peptides"
Products of "Peptides"
Sort by
H-LNIDLLWSV^-OH
Peptide H-LNIDLLWSV^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-LNIDLLWSV^-OH include the following: Vagaries of the ELISpot assay: Specific detection of antigen responsive cells requires purified CD8+ T cells and MHC class I expressing antigen presenting cell lines YF Fuchs, GW Jainta, D Kuhn, C Wilhelm, M Weigelt - Clinical , 2015 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1521661615000613 Early-versus late-onset type 1 diabetes: two different pathophysiological subtypes with implications for therapy WM Kuhtreiber, M Davis - and Immune-based , 2017 - books.google.comhttps://books.google.com/books?hl=en&lr=&id=6PiODwAAQBAJ&oi=fnd&pg=PA27&dq=(%22LNIDLLWSV%5E%22+OR+%22H-LNIDLLWSV-OH%22+OR+%22H-LNIDLLWSV%5E-OH%22+OR+%22LNIDLLWSV%22)+AND+peptide&ots=C70ie99trV&sig=WzURAJi5CBYs712JP1rpWtDaRmY Early-versus late-onset type 1 diabetes: two different pathophysiological subtypes with implications for therapy WM Kuhtreiber, M Davis - and Immune-based , 2017 - books.google.comhttps://books.google.com/books?hl=en&lr=&id=6PiODwAAQBAJ&oi=fnd&pg=PA27&dq=(%22LNIDLLWSV%5E%22+OR+%22H-LNIDLLWSV-OH%22+OR+%22H-LNIDLLWSV%5E-OH%22+OR+%22LNIDLLWSV%22)+AND+peptide&ots=C70ie99ulX&sig=WrEdarajDVkJ7L_W-9gvD5p35Yo Novel automated blood separations validate whole cell biomarkers DE Burger, L Wang, L Ban , Y Okubo, WM Kuhtreiber - PLoS , 2011 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.002243026Rfa, Hypothalamic Peptide, human
CAS:Custom research peptide; min purity 95%. For different specs please use the Peptide Quote ToolFormula:C127H195N37O37Molecular weight:2,832.17 g/molPTGS1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PTGS1 antibody, catalog no. 70R-1882Purity:Min. 95%Nesfatin-1 (30-59) (Human)
Nesfatin-1 (30-59) is a peptide that is isolated from the brain and has been shown to have the ability to regulate feeding behavior. It is thought to be involved in the regulation of appetite and body weight. Nesfatin-1 (30-59) has been shown to inhibit ghrelin secretion, which is a hormone involved in hunger and satiety. This peptide also appears to stimulate insulin secretion by pancreatic beta cells, which may contribute to its anti-diabetic effects.Formula:C167H263N41O54Purity:Min. 95%Molecular weight:3,709.2 g/molKHDRBS3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of KHDRBS3 antibody, catalog no. 70R-4610Purity:Min. 95%Copine IX Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CPNE9 antibody, catalog no. 70R-4191Purity:Min. 95%vMIP-II (1-21) TFA
vMIP-II (1-21) (NT21MP) TFA (TFA is a potent inhibitor of CXCR4. This compound interacts broadly with CC and CXC chemokine receptors. Furthermore, vMIP-II (1-21) TFA inhibits CXCR4 by competing for binding sites with 125I-SDF-1R, exhibiting an IC50 value of 190 nM.Color and Shape:Odour SolidH-THFPQFSYSASIR^E-OH
Peptide H-THFPQFSYSASIR^E-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-THFPQFSYSASIR^E-OH include the following: How iMALDI can improve clinical diagnostics R Popp, M Basik, A Spatz , G Batist , RP Zahedi - Analyst, 2018 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2018/an/c8an00094h Immuno-MALDI (iMALDI) mass spectrometry for the analysis of proteins in signaling pathways R Popp, H Li , CH Borchers - Expert Review of Proteomics, 2018 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/14789450.2018.1516147 Immuno-matrix-assisted laser desorption/ionization assays for quantifying AKT1 and AKT2 in breast and colorectal cancer cell lines and tumors R Popp, H Li , A LeBlanc, Y Mohammed - Analytical , 2017 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.analchem.7b02934 Systematic optimization of the iMALDI workflow for the robust and straightforward quantification of signaling proteins in cancer cells BC Froehlich, R Popp, CA Sobsey - PROTEOMICS , 2020 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/prca.202000034TTC27 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TTC27 antibody, catalog no. 70R-9467Purity:Min. 95%PLA2G5 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PLA2G5 antibody, catalog no. 70R-5351Purity:Min. 95%H-QMVQQFK-OH
Peptide H-QMVQQFK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-QMVQQFK-OH include the following: beta-1,3-Glucanase Activity in Peanut Seed (Arachis hypogaea) is Induced by Inoculation with Aspergillus flavus and Copurifies with a Conglutin-Like Protein XQ Liang, CC Holbrook, RE Lynch, BZ Guo - Phytopathology, 2005 - Am Phytopath Societyhttps://apsjournals.apsnet.org/doi/abs/10.1094/PHYTO-95-0506N-(2,4-Dinitrophenyl)-L-phenylalanine
CAS:Formula:C15H13N3O6Purity:>98.0%(T)(HPLC)Color and Shape:Light yellow to Yellow to Orange powder to crystalMolecular weight:331.28H-AGEDPHGYFLPGQFA-OH
Peptide H-AGEDPHGYFLPGQFA-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-AGEDPHGYFLPGQFA-OH include the following: Proteolytic regulatory mechanism of chemerin bioactivity XY Du, LLK Leung - Acta Biochim Biophys Sin, 2009 - academic.oup.comhttps://academic.oup.com/abbs/article-abstract/41/12/973/628 New roles of the multidimensional adipokine: chemerin SS Fatima , R Rehman , M Baig , TA Khan - Peptides, 2014 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0196978114002885 Chemerin Peptides Promote SD Manner - J. Immunol, 2010 - biosyn.comhttp://www.biosyn.com/images/articleimages/pdf/chemerin.pdf Mouse ChemR23 is expressed in dendritic cell subsets and macrophages, and mediates an anti-inflammatory activity of chemerin in a lung disease model S Luangsay, V Wittamer , B Bondue - The Journal of , 2009 - journals.aai.orghttps://journals.aai.org/jimmunol/article/183/10/6489/81558?utm_source=TrendMD&utm_medium=cpc&utm_campaign=J_Immunol_TrendMD_0 Chemerin contributes to inflammation by promoting macrophage adhesion to VCAM-1 and fibronectin through clustering of VLA-4 and VLA-5 R Hart, DR Greaves - The Journal of Immunology, 2010 - journals.aai.orghttps://journals.aai.org/jimmunol/article/185/6/3728/39204 Computational modeling of full-length prochemerin from human Q Huang, T Xiao, JV Zhang - Proceedings of 2012 IEEE-EMBS , 2012 - ieeexplore.ieee.orghttps://ieeexplore.ieee.org/abstract/document/6211693/ Vascular stent with immobilized anti-inflammatory chemerin 15 peptides mitigates neointimal hyperplasia and accelerates vascular healing L Wen, H Qiu, S Li, Y Huang, Q Tu, N Lyu, X Mou - Acta Biomaterialia, 2024 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1742706124000904 Identification of a stable chemerin analog with potent activity toward ChemR23 K Shimamura, M Matsuda, Y Miyamoto, R Yoshimoto - Peptides, 2009 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0196978109002137 Chemerin, a novel adipokine in the regulation of angiogenesis K Bozaoglu , JE Curran , CJ Stocker - The Journal of , 2010 - academic.oup.comhttps://academic.oup.com/jcem/article-abstract/95/5/2476/2597606 Chemerin peptides promote phagocytosis in a ChemR23-and Syk-dependent manner JL Cash , AR Christian, DR Greaves - The Journal of Immunology, 2010 - journals.aai.orghttps://journals.aai.org/jimmunol/article/184/9/5315/83338 Chemerin and male reproduction: aca¢ââ¬ÃÅ a tangled ropeaca¢ââ¬â¢connecting metabolism and inflammation FF Liew , S Dutta , P Sengupta - Chemical Biology , 2021 - pubs.iscience.inhttp://www.pubs.iscience.in/journal/index.php/cbl/article/view/1265 Chemerin/chemR23 axis in inflammation onset and resolution F Mariani, L Roncucci - Inflammation Research, 2015 - Springerhttps://link.springer.com/article/10.1007/s00011-014-0792-75Fam-CRGDK-OH
Peptide 5Fam-CRGDK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using 5Fam-CRGDK-OH include the following: Internalizing RGD, a great motif for targeted peptide and protein delivery: a review article Z Davoodi, F Shafiee - Drug Delivery and Translational Research, 2022 - Springerhttps://link.springer.com/article/10.1007/s13346-022-01116-7 Tumor-targeting peptide for redox-responsive Pt prodrug and gene codelivery and synergistic cancer chemotherapy Y Bai, Z Li, L Liu, T Sun, X Fan, T Wang - ACS Applied Bio , 2019 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsabm.9b00065 Increased antitumor activity of tumor-specific peptide modified thymopentin X Lao, B Li, M Liu, J Chen, X Gao, H Zheng - Biochimie, 2014 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0300908414002624 Does ligand-receptor mediated competitive effect or penetrating effect of iRGD peptide when co-administration with iRGD-modified SSL? WQ Zhang, KF Yu, T Zhong , LM Luo, R Du - Journal of drug , 2015 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.3109/1061186X.2015.1034279 Peptide-functionalized delivery vehicles for enhanced cancer therapy SY Tang, H Wei, CY Yu - International Journal of Pharmaceutics, 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0378517320311261 Peptide-mediated cancer targeting of nanoconjugates S Raha , T Paunesku - Wiley Interdisciplinary , 2011 - Wiley Online Libraryhttps://wires.onlinelibrary.wiley.com/doi/abs/10.1002/wnan.121 Neuropilin-1 Binding Peptide as Fusion to Diphtheria Toxin Induces Apoptosis in Non-small Cell Lung Cancer Cell Line S Eghtedari, M Behdani - Current , 2024 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cpd/2024/00000030/00000017/art00003 Developments in tumor targeting and internalizing peptides RIC Padanha - 2017 - repositorio.ul.pthttps://repositorio.ul.pt/handle/10451/36085 Peptide-based nanoprobes for molecular imaging and disease diagnostics P Zhang , Y Cui, CF Anderson , C Zhang, Y Li - Chemical Society , 2018 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2018/cs/c7cs00793k Homing peptides for cancer therapy P Lingasamy , T Teesalu - Bio-nanomedicine for cancer therapy, 2021 - Springerhttps://link.springer.com/chapter/10.1007/978-3-030-58174-9_2 Tumor penetrating peptide-functionalized tenascin-C antibody for glioblastoma targeting P Lingasamy , AH Laarmann - Current cancer drug , 2021 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/ccdt/2021/00000021/00000001/art00006 A versatile theranostic nanodevice based on an orthogonal bioconjugation strategy for efficient targeted treatment and monitoring of triple negative breast cancer MV Cano-Cortes , SA Navarro-Marchal - , Biology and Medicine, 2020 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1549963419302047 Peptide-modified nanoparticles for tumor targeting and molecular imaging L Lu, Q Zhang, Z Wang, L Gao - Current Medicinal , 2021 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cmc/2021/00000028/00000031/art00009 De Novo Design of a Tumor-Penetrating Peptide L Alberici, L Roth, KN Sugahara, L Agemy - Cancer research, 2013 - AACRhttps://aacrjournals.org/cancerres/article-abstract/73/2/804/590737 Proapoptotic peptide-mediated cancer therapy targeted to cell surface p32 L Agemy, VR Kotamraju, D Friedmann-Morvinski - Molecular Therapy, 2013 - cell.comhttps://www.cell.com/molecular-therapy-family/molecular-therapy/fulltext/S1525-0016(16)30945-5 Tissue-penetrating delivery of compounds and nanoparticles into tumors KN Sugahara, T Teesalu , PP Karmali, VR Kotamraju - Cancer cell, 2009 - cell.comhttps://www.cell.com/cancer-cell/pdf/S1535-6108(09)00382-1.pdf A tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosis KN Sugahara, P Scodeller , GB Braun - Journal of Controlled , 2015 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365915006161 Cell-Penetrating Peptide-Conjugated BF2-Oxasmaragdyrins as NIRF Imaging and Photothermal Agents K Laxman , BPK Reddy , A Robinson - , 2020 - Wiley Online Libraryhttps://chemistry-europe.onlinelibrary.wiley.com/doi/abs/10.1002/cmdc.202000401 Use of Chitosan from Southern King Crab to Develop Films Functionalized with RGD Peptides for Potential Tissue Engineering Applications JC Forero , K Carvajal, F Guzman, C Acevedo, N Osses - Biomimetics, 2023 - mdpi.comhttps://www.mdpi.com/2313-7673/8/3/323 Integrin-targeting peptides for the design of functional cell-responsive biomaterials J Zhao, F Santino, D Giacomini, L Gentilucci - Biomedicines, 2020 - mdpi.comhttps://www.mdpi.com/2227-9059/8/9/307 Theranostic iRGD peptide containing cisplatin prodrug: Dual-cargo tumor penetration for improved imaging and therapy HJ Cho , SJ Park, YS Lee , S Kim - Journal of controlled release, 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365919301269 Activatable iRGD-based peptide monolith: Targeting, internalization, and fluorescence activation for precise tumor imaging HJ Cho , SJ Lee, SJ Park, CH Paik, SM Lee - Journal of Controlled , 2016 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365916304096 A free cysteine prolongs the half-life of a homing peptide and improves its tumor-penetrating activity HB Pang , GB Braun , ZG She , VR Kotamraju - Journal of Controlled , 2014 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365913009486 iRGD: a promising peptide for cancer imaging and a potential therapeutic agent for various cancers H Zuo - Journal of Oncology, 2019 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1155/2019/9367845 Peptide-decorated polymeric nanomedicines for precision cancer therapy H Sun , Y Dong, J Feijen , Z Zhong - Journal of controlled release, 2018 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365918305686 Acid-responsive PEGylated doxorubicin prodrug nanoparticles for neuropilin-1 receptor-mediated targeted drug delivery H Song, J Zhang, W Wang , P Huang, Y Zhang - Colloids and Surfaces B , 2015 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0927776515301995 Amphipathic tail-anchoring peptide is a promising therapeutic agent for prostate cancer treatment G De, JK Ko , T Tan, H Zhu , H Li , J Ma - Oncotarget, 2014 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202157/ CRGDK-functionalized PAMAM-based drug-delivery system with high permeability D Liu, C Wang, J Yang, Y An, R Yang, G Teng - ACS omega, 2020 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsomega.0c00202 Targeted modification of the cationic anticancer peptide HPRP-A1 with iRGD to improve specificity, penetration, and tumor-tissue accumulation C Hu, Y Huang, Y Chen - Molecular Pharmaceutics, 2018 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.8b00854 Nrp-1 receptor targeting peptide-functionalized TPGS micellar nanosystems to deliver 10-hydroxycampothecin for enhanced cancer chemotherapy A Mozhi , I Ahmad , QM Kaleem, RG Tuguntaev - International journal of , 2018 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0378517318303880 Gold nanoparticles functionalized with therapeutic and targeted peptides for cancer treatment A Kumar , H Ma, X Zhang , K Huang, S Jin , J Liu , T Wei - Biomaterials, 2012 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0142961211012622 Peptide-based strategies for targeted tumor treatment and imaging A Ayo, P Laakkonen - Pharmaceutics, 2021 - mdpi.comhttps://www.mdpi.com/1999-4923/13/4/481